Outcomes with ibrutinib in patients with chronic lymphocytic leukaemia: Results from the German multicentre REALITY study. Gerhardt A, Dorfel S, Schulz H, Schlag R, et al. Eur J Haematol 2024;112:927-937.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gerhardt A, Dorfel S, Schulz H, Schlag R, et al. Outcomes with ibrutinib in patients with chronic lymphocytic leukaemia: Results from the German multicentre REALITY study. Eur J Haematol 2024;112:927-937.
PMID: 38342972